NeuroNova AB

NeuroNova AB

NeuroNova wants to recharge neurons. The biopharmaceutical company is engaged in the research and development of therapies to help regenerate central nervous system cells in patients with Alzheimer's disease, Parkinson's disease, and other disorders. Its research focuses on developing drugs that will stimulate endogenous stem and progenitor cells to restore damaged areas of the brain. The company has two drug candidates nearing clinical development in addition to other compounds in the discovery and pre-clinical phases. NeuroNova was founded in 1998 and is financed by Swedish venture capital companies HealthCap, Scandinavian Life Science Venture, and Investor Growth Capital.

Contact Details

Office Address

NeuroNova AB
Fiskartorpsvägen 15 A-D, Stockholm, Sweden SE-114 33
Phone: +46-8-786-0900
Fax: +46-8-786-0911

Executives

Chairman

Carl-Gustaf Johansson

President and CEO

Ulf Ljungberg

Business Reviews for NeuroNova AB

Related Companies